(Q51912002)

17 April 2018

review article

1 reference

title

Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? (English)

1 reference

17 April 2018

1 reference

Christos Sotiriou

1

1 reference

17 April 2018

Martine J Piccart

series ordinal

2

1 reference

17 April 2018

language of work or name

English

0 references

publication date

1 July 2007

1 reference

17 April 2018

published in

Nature Reviews Cancer

1 reference

17 April 2018

volume

7

1 reference

17 April 2018

page(s)

545-553

1 reference

17 April 2018

issue

7

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1038/nrc2173

exact match

0 references

cites work

The lifetime risk of developing breast cancer

1 reference

Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.

21 January 2018

1 reference

First--select the target: better choice of adjuvant treatments for breast cancer patients.

21 January 2018

1 reference

Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

21 January 2018

1 reference

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

21 January 2018

1 reference

Microarray results: how accurate are they?

21 January 2018

1 reference

Evaluation of gene expression measurements from commercial microarray platforms

21 January 2018

1 reference

Validation of a novel, fully integrated and flexible microarray benchtop facility for gene expression profiling.

21 January 2018

1 reference

Spotted long oligonucleotide arrays for human gene expression analysis.

21 January 2018

1 reference

Microarrays Technologies 2006: an overview.

21 January 2018

1 reference

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

21 January 2018

1 reference

Rat toxicogenomic study reveals analytical consistency across microarray platforms

21 January 2018

1 reference

Embracing the complexity of genomic data for personalized medicine

21 January 2018

1 reference

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival

21 January 2018

1 reference

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

21 January 2018

1 reference

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

21 January 2018

1 reference

A DNA-Binding Protein Helps Repair Breaks in DNA Double Helix

21 January 2018

1 reference

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness

21 January 2018

1 reference

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients

21 January 2018

1 reference

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

21 January 2018

1 reference

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

21 January 2018

1 reference

A consensus prognostic gene expression classifier for ER positive breast cancer

21 January 2018

1 reference

Proliferation: the most prominent predictor of clinical outcome in breast cancer

21 January 2018

1 reference

Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas.

21 January 2018

1 reference

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

21 January 2018

1 reference

The prognostic role of a gene signature from tumorigenic breast-cancer cells.

21 January 2018

1 reference

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

Genes associated with breast cancer metastatic to bone

21 January 2018

1 reference

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

21 January 2018

1 reference

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study

21 January 2018

1 reference

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

21 January 2018

1 reference

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

21 January 2018

1 reference

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer.

21 January 2018

1 reference

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients

21 January 2018

1 reference

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

21 January 2018

1 reference

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.

21 January 2018

1 reference

From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression

21 January 2018

1 reference

Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics

21 January 2018

1 reference

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

21 January 2018

1 reference

Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction

21 January 2018

1 reference

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

21 January 2018

1 reference

Multiplexed biochemical assays with biological chips

21 January 2018

1 reference

Microarray platforms--comparisons and contrasts.

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

Impact of cyclins E, neutrophil elastase and proteinase 3 expression levels on clinical outcome in primary breast cancer patients.

21 January 2018

1 reference

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

Keeping faith with trial volunteers

21 January 2018

1 reference

Interlaboratory variation in results from immunohistochemical assessment of estrogen receptor status

21 January 2018

1 reference

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting

31 March 2020

1 reference

Outcome signature genes in breast cancer: is there a unique set?

31 March 2020

1 reference

A gene-expression signature to predict survival in breast cancer across independent data sets.

31 March 2020

1 reference

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

31 March 2020

1 reference

New technologies for high-throughput analysis

31 March 2020

1 reference

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

31 March 2020

1 reference

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

31 March 2020

1 reference

Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

31 March 2020

1 reference

Prediction of docetaxel response in human breast cancer by gene expression profiling.

31 March 2020

1 reference

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

31 March 2020

1 reference

Reporting recommendations for tumor marker prognostic studies (REMARK).

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC2173

1 reference

17 April 2018

PubMed ID

17585334

1 reference

17 April 2018